ARID1A and colorectal carcinoma: In conclusion, our study shows that radiosensitivity in ARID1A mutant CRC cell lines can selectively be increased through depletion of ARID1B, suggesting ARID1B as a potential therapeutic target to increase radiosensitivity in ARID1A-deficient tumors.